L
MyProstateScore 2.0 is a personalized, comprehensive, data-driven prostate cancer screening solution designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7). The algorithm is specifically optimized for unrivaled accuracy for both previously negative biopsy and biopsy naïve patients.
Investor insights
Funding rounds participated in
$925K sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2015
Funding rounds raised
Total raised
$925K
from investors over 1 rounds
L
Lynx Dx raised $925K on February 27, 2020